4//SEC Filing
ENTELLUS MEDICAL INC 4
Accession 0001235802-15-000017
CIK 0001374128operating
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:19 PM ET
Size
27.1 KB
Accession
0001235802-15-000017
Insider Transaction Report
Form 4
Split Rock Partners Management LLC
10% Owner
Transactions
- Conversion
Series D Convertible Preferred Stock
2015-02-03−2,754,034→ 0 total→ Common Stock (688,508 underlying) - Conversion
Series C Convertible Preferred Stock
2015-02-03−743,466→ 0 total→ Common Stock (250,876 underlying) - Conversion
Common Stock
2015-02-03+621,547→ 921,547 total - Purchase
Common Stock
2015-02-03$17.00/sh+352,941$5,999,997→ 3,156,731 total - Conversion
Common Stock
2015-02-03+250,876→ 1,172,423 total - Conversion
Common Stock
2015-02-03+688,508→ 1,860,931 total - Conversion
Series A Convertible Preferred Stock
2015-02-03−1,200,000→ 0 total→ Common Stock (300,000 underlying) - Conversion
Common Stock
2015-02-03+300,000→ 300,000 total - Conversion
Common Stock
2015-02-03+942,859→ 2,803,790 total - Conversion
Series B Convertible Preferred Stock
2015-02-03−2,486,188→ 0 total→ Common Stock (621,547 underlying) - Conversion
Series E Convertible Preferred Stock
2015-02-03−3,771,438→ 0 total→ Common Stock (942,859 underlying)
Split Rock Partners, LP
10% Owner
Transactions
- Conversion
Common Stock
2015-02-03+621,547→ 921,547 total - Conversion
Series C Convertible Preferred Stock
2015-02-03−743,466→ 0 total→ Common Stock (250,876 underlying) - Conversion
Series E Convertible Preferred Stock
2015-02-03−3,771,438→ 0 total→ Common Stock (942,859 underlying) - Conversion
Common Stock
2015-02-03+300,000→ 300,000 total - Conversion
Common Stock
2015-02-03+250,876→ 1,172,423 total - Conversion
Common Stock
2015-02-03+942,859→ 2,803,790 total - Conversion
Series B Convertible Preferred Stock
2015-02-03−2,486,188→ 0 total→ Common Stock (621,547 underlying) - Conversion
Common Stock
2015-02-03+688,508→ 1,860,931 total - Purchase
Common Stock
2015-02-03$17.00/sh+352,941$5,999,997→ 3,156,731 total - Conversion
Series A Convertible Preferred Stock
2015-02-03−1,200,000→ 0 total→ Common Stock (300,000 underlying) - Conversion
Series D Convertible Preferred Stock
2015-02-03−2,754,034→ 0 total→ Common Stock (688,508 underlying)
Footnotes (4)
- [F1]Reflects a 1-for-4 reverse stock split effected as of January 12, 2015.
- [F2]Each outstanding share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series D Convertible Preferred Stock and Series E Convertible Preferred Stock automatically converted into 1/4 of a share of the Issuer's common stock, immediately prior to the closing of the Issuer's initial public offering, for no additional consideration (subject to payment of cash for any fractional shares, in accordance with the Issuer's certificate of incorporation). These shares had no expiration date.
- [F3]The securities are owned directly by Split Rock Partners, LP ("SRP"). Voting and investment power over the securities is delegated to Split Rock Partners Management, LLC ("SRPM"), the general partner of SRP. SRPM has delegated voting and investment decisions to Michael Gorman, James Simons and David Stassen (collectively, the "General Partner Designees"), who require a two-thirds vote to act. Each of the General Partner Designees disclaims beneficial ownership of the securities except to the extent of any pecuniary interest therein.
- [F4]Each outstanding share of Series C Convertible Preferred Stock automatically converted into 0.3374 of a share of the Issuer's common stock, immediately prior to the closing of the Issuer's initial public offering, for no additional consideration (subject to payment of cash for any fractional shares, in accordance with the Issuer's certificate of incorporation). These shares had no expiration date.
Documents
Issuer
ENTELLUS MEDICAL INC
CIK 0001374128
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001374128
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:19 PM ET
- Size
- 27.1 KB